Jacob Shaul
CACI International (United States)(US)Novartis (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Polyomavirus and related diseases, Antenna Design and Analysis, Full-Duplex Wireless Communications, Antibiotics Pharmacokinetics and Efficacy
Most-Cited Works
- → Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae – Identification of LYS228(2018)58 cited
- → Two Distinct Mechanisms of Inhibition of LpxA Acyltransferase Essential for Lipopolysaccharide Biosynthesis(2020)39 cited
- → Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae(2018)39 cited
- → IID572: A New Potentially Best-In-Class β-Lactamase Inhibitor(2019)26 cited
- → Cryptosporidium PI(4)K inhibitor EDI048 is a gut-restricted parasiticidal agent to treat paediatric enteric cryptosporidiosis(2024)23 cited
- → The human IKKβ subunit kinase domain displays CK2-like phosphorylation specificity(2008)19 cited
- → Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1(2024)16 cited
- → Probing Kinase Activation and Substrate Specificity with an Engineered Monomeric IKK2(2014)13 cited
- A double-blinded, randomized, controlled clinical trial to compare cefazolin and cefonicid for antimicrobial prophylaxis in clean orthopedic surgery.(1995)
- → A polyomavirus peptide binds to the capsid VP1 pore and has potent antiviral activity against BK and JC polyomaviruses(2020)9 cited